Background: In this study, we assessed the prognostic value of the lymph node ratio (LNR), established a hypothetical tumor-ratio-metastasis (TRM) staging system and compared it with the 7th edition International Union Against Cancer pathological N (pN) and tumor-node-metastasis (TNM) system.
introduction
Gastric cancer is the fourth most common malignant tumor worldwide, with an estimated 1 million new cases every year [1] . More new cases of gastric cancer are diagnosed in China each year than any other country [2] . In this year, the 7th edition International Union Against Cancer (UICC) tumornode-metastasis (TNM) staging system was published [3] . It can provide a reliable prognostic information of gastric cancer than the 6th edition and has also been adopted by the Japanese Gastric Cancer Association (JGCA) [4, 5] . While the number of metastatic lymph nodes (MLN) identified depends on the surgical and pathologic procedure. In cases where few nodes are retrieved, patients cannot be classified consistently according to the number of MLN, which is also referred to stage migration [6] [7] [8] [9] . Recently, a new prognostic tool of lymph node ratio (LNR), defined as the number of MLN divided by the number of lymph nodes retrieved, was proposed. It was found to improve prognostic information and reduce the stage migration when compared with the UICC (2002, 6th edition) or JGCA (1998, 2nd English edition) staging system [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
However, whether the 7th edition pathological N (pN) stage is optimal for prognosis or whether the LNR stage is more suitable for prognosis than it is still unknown. To date, there has been no formal proposal focused on comparing the prognostic significance between LNR and the 7th edition UICC pN stage. Hence, in this article, we investigated whether patients with gastric cancer can be classified into meaningful risk categories based on LNR, by comparing this stage with the 7th edition pN stage. Then, we investigated the prognostic value of the tumor-ratio-metastasis (TRM) hypothetical staging system and compared it with the 7th edition UICC TNM system.
patients and methods patients
Clinic-pathological data from 1580 cases of gastric cancer patients who underwent surgical resection from January 1994 to December 2006 at Sun 
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Yat-sen University Cancer Center were analyzed retrospectively. The eligibility criteria included histologically confirmed R0 resection, which was defined as no macroscopic and microscopic residual tumor and a postoperative survival time of ‡3 months. Patients with distant metastases and carcinoma of the gastric stump after gastric resection for benign disease were excluded from the study. Among the potential participants, 106 had distant metastases (liver, lung, ovary, abdominal or pelvic cavity dissemination), 41 underwent R1 or R2 resection, which means with macroscopic and microscopic residual tumor, 13 had distant lymph node metastases (retropancreatic, mesenteric, duodenohepatic ligament or para-aortic lymph node), 15 died <3 months after resection, and 62 were lost to follow-up. Thus, 237 patients were excluded.
D2 lymphadenectomy was carried out by experienced surgeons following the JGCA guidelines [24] . A total of 20 047 lymph nodes were retrieved, with a mean of 14.93 6 10.07 lymph nodes per patient (23.34 6 19.14 for patients with >15 lymph nodes retrieved and 8.10 6 3.46 for patients with £15 lymph nodes retrieved) and a range from 3 to 72. The mean number of MLN was 4.13 6 6.12 per patient (8.79 6 8.50 for patients with >15 lymph nodes retrieved and 4.09 6 2.72 for patients with £15 lymph nodes retrieved) with a range from 1 to 70. Lymph node metastasis was classified according to the 7th edition UICC N stage [3] (pN0: no metastasis; pN1: 1-2 MLN; pN2: 3-6 MLN; pN3: ‡7 MLN).
To make the study compatible with the 7th edition UICC TNM staging system, a novel TRM hypothetical staging system on the basis of T stage and N ratio was proposed as seven prognostically homogeneous TRM classes of patients (IA: T1R0; IB: T1R1, T2R0; IIA: T1R2, T2R1, T3R0; IIB:  T1R3, T2R2, T3R1, T4aR0; IIIA: T2R3, T3R2, T4aR1; IIIB: T3R3, T4aR2,  T4bR0-1; IIIC: T4aR3, T4bR2-3) . This study does not include stage IV patients according to the 7th edition TNM system because all the patients enrolled underwent radical resection and had no distant metastasis. To investigate which N stage has more potential in minimizing stage migration when an insufficient number of lymph nodes are retrieved, all the patients enrolled in this study were divided into groups with sufficient numbers (>15 lymph nodes retrieved) and insufficient numbers (£15 lymph nodes retrieved) of lymph nodes retrieved.
Postoperative follow-up included clinical and laboratory examinations every 3 months for the first 2 years at our outpatient department, every 6 months from the third to the fifth years, and annually thereafter until at least 5 years after the operation or until the patient died, whichever came first. Overall patient survival, defined as the time from operation to death or last follow-up, was used as a measure of prognosis. The median follow-up for the entire cohort was 50 months (range 3-197 months). The follow-up was closed in May 2010.
statistical analysis
The analysis for best cut points was investigated as follows. First, patients having no MLN (LNR = 0) were fixed into one group because it has been well documented that their prognosis significantly differs from patients with MLN. Then, X-tile (http://www.tissuearray.org/rimmlab/) was used to group the rest of the patients [25] . In our study, the two other cut points from X-tile for LNR were 0.27 and 0.62. For the sake of convenience in clinical interpretation and application, the cut points were adjusted to 0.30 and 0.60. Martingale residual analysis was also used to examine the classification of LNR, and our cut points (0, 0.30, and 0.60) were found to be consistent. After numerous evaluations, no other sets of cut points were found to perform better in our data. Thus, four subgroups of LNR classification (LNR0, 0%; LNR1, 1%-30%; LNR2, 31%-60%; LNR3, 61%-100%) were determined for our study. Finally, to estimate the stability of the results, we used a bootstrap procedure, which applies the proportional hazards computations to full random samples with replacement of the patients. We ran 10 000 iterations of this procedure.
To compare the homogeneity of the TRM system with that of the TNM system, the likelihood ratio v 2 test related to the Cox regression model was used. The discriminatory ability and monotonicity of gradient assessments were measured with the linear trend v 2 test. The Akaike information criterion (AIC) value within a Cox proportional hazard regression model also was calculated for each system to measure its discriminatory ability. The AIC statistic was defined by AIC = 22 log maximum likelihood + 2 · the number of parameters in the model. A smaller AIC value indicates a more desirable model for predicting outcome [26] [27] [28] [29] [30] .
The 5-year survival rate was calculated using the Kaplan-Meier method. Statistical comparisons of different factors were made with the log-rank test. In multivariate analysis, forward stepwise regression analysis was carried out with a Cox proportional hazards model. A P value of £0.05 was considered statistically significant. All statistical analyses were carried out using SPSS software version 18.0 (SPSS Inc., Chicago, IL).
results
Of the 1343 patients, 902 (67.2%) were males, and 441 (32.8%) were females. The mean age of the patients was 56.4 6 11.9 years (range 17-85 years). The overall 5-year survival rate for all patients was 55.9%, and 730 patients were alive when our follow-up was completed.
univariate and multivariate survival analyses
Ten factors were found to have statistically significant associations with the overall survival upon univariate analysis, which were age, tumor location, tumor size, histological grade, type of gastrectomy, lymphatic/venous invasion, pathological T (pT), pN, LNR, and the number of retrieved lymph nodes (Table 1 ). All the aforementioned 10 variables were included in a multivariate Cox proportional hazards model to adjust for the effects of covariates. In our study, the pN and LNR classifications were highly correlated. Therefore, two separate multivariate models, one with pN and the other with LNR, were run to avoid problems with the presence of multicollinearity. In that model, we demonstrated that age, tumor location, tumor size, type of gastrectomy, histological grade, lymphatic/venous invasion, pT, pN, LNR, and the number of retrieved lymph nodes remained independent prognostic factors ( Table 2) .
The 5-year survival rates according to each N and LNR stage are shown in Figure 1 . With both the N and the LNR stage, the Kaplan-Meier plots showed a good discriminatory ability among each group ( Figure 1A and B). The 5-year survival rates of N0, N1, N2, and N3 patients were 77.5%, 59.5%, 44.1%, and 30.8%, respectively (P < 0.001, <0.001 and =0.001, respectively). The 5-year survival rates of LNR0, LNR1, LNR2, and LNR3 patients were 77.5%, 64.3%, 39.7%, and 22.3%, respectively (P < 0.001, <0.001 and <0.001, respectively). When stratified analysis was used by the number of retrieved lymph nodes, the Kaplan-Meier plot also showed a good discriminatory ability between each group in both N and LNR stages, except for N1 versus N2 in the sufficient number group (P = 0.076) (Figure 2) . Figure 1 also lists the patient distribution and stage-specific survival rates. By analyzing all the seven substages in the TNM staging system, we found that there were similar survival curves between stages IB and IIA (P = 0.261), while the Kaplan-Meier plot showed no overlapping survival curves among the other subgroups. On the other hand, in the TRM staging system, the Kaplan-Meier plot showed a good discriminatory ability among all the seven substages ( Figure 1C and D) .
In stratified analysis based on the number of retrieved lymph nodes, we investigated survival curves in both staging systems according to the insufficient and sufficient number group. In the TNM staging system, with the insufficient number group, the survival curves between IB and IIA were similar (P = 0.222). In the sufficient number group, no significant differences were found between IA and IB and IB and IIA (P = 0.240 and 0.149, respectively), and overlapping survival curves were found between IIB and IIIA (P = 0.765). With respect to the TRM staging system, no significant differences between the survival curves were found between IB and IIA in the insufficient number group and between IA and IB in the sufficient number group (P = 0.150 and 0.276, respectively) ( Figure 3) . The performance between the TNM and TRM staging systems, as well as between the N and LNR stage, as assessed by the linear trend v 2 , likelihood ratio v 2 , and the AIC tests is described in Table 3 . Compared with the TNM staging system, the TRM staging system had better homogeneity (higher likelihood ratio v 2 score, 335.211 versus 292.934), discriminatory ability, and monotonicity of gradients (higher linear trend v 2 score, 292.880 versus 259.754). Furthermore, in our study, the TRM staging system had a smaller AIC value (8121.395 versus 8167.298), representing the optimum prognostic stratification.
discussion
Studies have demonstrated that staging by the LNR is superior to staging by the absolute number of MLN in predicting Figure 1 . Impact of the pN (A), LNR (B), TNM (C), and TRM (D) staging on postoperative cancer-related survival. (A) pN stage: pN0 versus pN1, P < 0.001; pN1 versus pN2, P < 0.001; pN2 versus pN3, P = 0.001; (B) LNR stage: LNR0 versus LNR1, P < 0.001; LNR1 versus LNR2, P < 0.001; LNR2 versus LNR3, P < 0.001; (C) TNM staging system: IA versus IB, P = 0.002; IB versus IIA, P = 0.261; IIA versus IIB, P < 0.001; IIB versus IIIA, P = 0.020; IIIA versus IIIB, P = 0.003; IIIB versus IIIC, P < 0.001; (D) TRM staging system: IA versus IB, P = 0.006; IB versus IIA, P = 0.040; IIA versus IIB, P = 0.001; IIB versus IIIA, P = 0.048; IIIA versus IIIB, P < 0.001; IIIB versus IIIC, P < 0.001. LNR, lymph node ratio; TNM, tumor-node-metastasis; TRM, tumorratio-metastasis.
original article Annals of Oncology prognosis of gastric cancer patients [11, [13] [14] [15] [16] [17] [18] [20] [21] [22] . For example, Bando et al. [11] analyzed 650 cases of gastric cancer patients who underwent D2 curative gastrectomy and classified the cut points of LNR as 0, 0-0.1, 0.1-0.25, and ‡0.25. They concluded that the stage migration was present in 15% of the 6th edition UICC pN stage and 7% of the LNR stage. Marchet et al. [17] analyzed 1853 cases of gastric cancer patients from an Italian multicentric study and classified the best cut points of LNR as 0, 1%-9%, 10%-25%, and >25%. They concluded that in multivariate analysis, the LNR (but not the 6th edition UICC pN stage) was retained as an independent prognostic factor both in groups with sufficient numbers (>15 lymph nodes retrieved) and insufficient numbers (£15 lymph nodes retrieved). Furthermore, the implementation of LNR led to the identification of subgroups of patients prognostically more homogeneous than those classified by the TNM system. In our previous report, we demonstrated that LNR is an independent prognostic factor in gastric cancer after D2 resection regardless of the number of retrieved lymph nodes, which showed the superiority of LNR to MLN [21] .
In this study, all patients were stratified uniformly by undergoing D2 lymphadenectomy with R0 resection, but the number of lymph nodes retrieved in the majority of the patients (55.2%) was £15, and therefore, in these patients the N stage cannot be classified as N3 according to the 6th edition system. On the other hand, in the 7th edition system, patients might be classified as N3 as long as the number of retrieved lymph nodes was more than seven, and thus this revised edition system may reduce stage migration to some degree. While whether the predictive ability of the 7th edition system is optimal and whether it can minimize the stage migration are still unknown. and LNR (C and D) staging using stratified analysis according to lymph nodes retrieved. (A) pN stage in £15 lymph nodes retrieved group: pN0 versus pN1, P < 0.001; pN1 versus pN2, P < 0.001; pN2 versus pN3, P < 0.001; (B) pN stage in >15 lymph nodes retrieved group: pN0 versus pN1, P = 0.015; pN1 versus pN2, P = 0.076; pN2 versus pN3, P < 0.001; (C) LNR stage in £15 lymph nodes retrieved group: LNR0 versus LNR1, P < 0.001; LNR1 versus LNR2, P < 0.001; LNR2 versus LNR3, P = 0.001; (D) LNR stage in >15 lymph nodes retrieved group: LNR0 versus LNR1, P < 0.001; LNR1 versus LNR2, P = 0.001; LNR2 versus LNR3, P = 0.006. LNR, lymph node ratio.
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Our categorization reveals that LNR is one of the most important prognostic factors of gastric cancer and shows a clear advantage over the 7th edition UICC N stage for the following reasons: (i) In univariate analysis, the log-rank v 2 associated with the LNR (v 2 = 324.602) was larger than that of pN (v 2 = 208.034), indicating a higher statistical significance and TRM (C and D) staging using stratified analysis according to lymph nodes retrieved (A) TNM staging system in £15 lymph nodes retrieved group: IA versus IB, P = 0.013; IB versus IIA, P = 0.222; IIA versus IIB, P = 0.049; IIB versus IIIA, P = 0.002; IIIA versus IIIB, P = 0.010; IIIB versus IIIC, P < 0.001; (B) TNM staging system in >15 lymph nodes retrieved group: IA versus IB, P = 0.240; IB versus IIA, P = 0.149; IIA versus IIB, P = 0.023; IIB versus IIIA, P = 0.765; IIIA versus IIIB, P = 0.010; IIIB versus IIIC, P < 0.001; (C) TRM staging system in £15 lymph nodes retrieved group: IA versus IB, P = 0.020; IB versus IIA, P = 0.150; IIA versus IIB, P = 0.048; IIB versus IIIA, P = 0.036; IIIA versus IIIB, P = 0.032; IIIB versus IIIC, P < 0.001; (D) TRM staging system in >15 lymph nodes retrieved group: IA versus IB, P = 0.276; IB versus IIA, P = 0.035; IIA versus IIB, P = 0.041; IIB versus IIIA, P = 0.042; IIIA versus IIIB, P = 0.046; IIIB versus IIIC, P = 0.039. TNM, tumor-node-metastasis; TRM, tumor-ratio-metastasis. Table 3) .
Cut points for LNR have been proposed in numerous studies. However, optimal thresholds for LNR are not agreed upon, and the most appropriate method for deciding cut points differs among investigators. In previous reports, most determined cut points using the so-called 'best cut-off approach by log-rank test'. In these reports, LNR was divided by interval of 5% or 10% with the log-rank test of Kaplan-Meier estimates of the survival curves [11, [17] [18] [19] 22, 23] .
In our opinion, LNR should be classified as a continuous variable. Categorization of this type of variable has been proven to be associated with several problems, including loss of information [31, 32] , inflation of type I error rate [33] , increase in variance of estimated hazard ratios and decrease in efficiency of survival analysis [34] . Furthermore, these aforementioned methods are relatively subjectively or insufficiently validated. In our study, we fully considered the objectivity of the method for treating the LNR as a continuous covariate and the convenience in clinical interpretation and application. X-tile is a wellvalidated computer program to determine optimal cut points with the use of minimum P values from log-rank statistics. It can control the inflated type I error problem and minimize the loss of information resulting from multiple testing in minimum P value approaches through cross-validation [25] . Also, we validated the cut points by means of Martingale residual analysis. Finally, the bootstrap procedure also confirmed the stability of the cut points results, which showed a significance of 0.001 (detail data not shown).
Since our study has shown the superiority of LNR to the 7th edition UICC N stage, we intended to combine pT stage and LNR by comparing the hypothetical TRM staging system with the 7th edition UICC TNM system. The Kaplan-Meier plot showed a good discriminatory ability among each substage both in TNM and TRM systems, except for between IB and IIA (P = 0.261) in the TNM system. In stratified analysis, the TRM system also demonstrated good discriminatory ability among each of the substages, except for between IB and IIA in the insufficient number group and IA and IB in the sufficient number group, which may be due to the relatively small sample size and relatively high survival rate. In the TNM staging system, with the insufficient number group, the survival curves between IB and IIA were similar (P = 0.222). In the sufficient number group, no significant differences were found between IA and IB and IB and IIA (P = 0.240 and 0.149, respectively), and moreover, overlapping survival curves were found between IIB and IIIA (P = 0.765). Figure 2 shows the better discriminatory ability between each of the survival curves in the TRM system, which was relatively poorer in the TNM system.
According to Ueno et al. [35] , the performance of the staging system can be evaluated as homogeneity within subgroups, discriminatory ability between different groups, and monotonicity of gradients shown in the correlation between stages and survival rates. In our study, the TRM staging system performed better homogeneity (higher likelihood ratio v 2 score), discriminatory ability, and monotonicity of gradients (higher linear trend v 2 score). More importantly, in our study, the TRM staging system had a smaller AIC value, representing the optimum prognostic stratification and indicating the smallest loss of information for predicting outcome. These results demonstrated better prognostic stratifications of TRM staging system than the 7th edition TNM staging system.
We acknowledge several limitations in this study. Our sample population is from a single-institution experience and relatively small compared with the worldwide gastric cancer collaboration database and is based on a retrospective study. While the strengths of this study are that the surgical procedures (R0 resection plus D2 lymphadenectomy), pathologic examinations, and patient follow-up were uniform throughout the entire study period. Cancer staging is a dynamic process. As our understanding of cancer biology improves, the staging system will need to be revised accordingly. We believe that LNR-based TRM staging system might be investigated more than today in near future. Furthermore, the most important challenge facing current TNM system is how to interface with the great number of nonanatomic prognostic factors such as other clinicopathologic factors, molecular and genetic biomarkers that are currently in use or under study. It is inevitable that additional nonanatomic factors will be added to TNM staging system in the future.
In conclusion, we clearly identify four LNR categories that define gastric cancer prognosis more adequately than the 7th edition UICC pN categories. Furthermore, the novel TRM staging system is superior to the 7th edition UICC TNM staging system. We argue that TRM staging system may be considered as an alternative to current 7th edition UICC TNM staging system. 
